LEP and obesity due to melanocortin 4 receptor deficiency: As ginsenosides target the central nervous system (CNS), which regulates leptin sensitivity in the cerebral cortex to prevent obesity and decreases the risk of central inflammation in the hypothalamus (Jeon et al., 2021).